Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

In Heart Disease, Intravenous Therapies by SFSCTCAdminLeave a Comment

There is epidemiological evidence that metal contaminants may play a role in the development of atherosclerosis and its complications. Moreover, a recent clinical trial of a metal chelator had a surprisingly positive result in reducing cardiovascular events in a secondary prevention population, strengthening the link between metal exposure and cardiovascular disease (CVD). This is, therefore, an opportune moment to review evidence that exposure to metal pollutants, such as arsenic, lead, cadmium, and mercury, is a significant risk factor for CVD.


Leave a Comment